Casandra
Casandra Test Code AL92337Version 1 (DRAFT)
Performing Lab
Lab AllelicaLab Test ID N/A
Breast Risk Reveal™
Clinical Use
Order TestUse
Breast Risk Reveal™ is an integrated breast cancer risk assessment combining monogenic variants identified via clinical whole exome sequencing (WES), multi‑ancestry polygenic risk scores (PRS), and established clinical models (e.g., Tyrer‑Cuzick, BOADICEA) to produce a unified lifetime risk estimate for breast cancer that enhances precision and equity across ancestries.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS
Biomarkers
Genetic Risk Assessment
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Not provided.
Similar Tests
Other tests from different labs that may be relevant
Breast Cancer - High Risk Panel
Prevention Genetics
Hereditary Breast Cancer Guidelines-Based Panel, Sequencing and Deletion/Duplication
ARUP Laboratories
VistaSeq® High/Moderate Risk Breast Cancer Panel
Labcorp
Invitae Hereditary Breast Cancer Guidelines-Based Panel
Invitae Corporation
VistaSeq® Breast Cancer Panel
Labcorp
Invitae Hereditary Breast Cancer Panel
Invitae Corporation
Hereditary Breast Cancer High-Risk Panel, Sequencing and Deletion/Duplication
ARUP Laboratories
BRCAplus
Ambry Genetics
BRCANext®
Ambry Genetics
Rapid Hereditary Breast Cancer Treatment Decision Panel, Varies
Mayo Clinic Lab